Table 1 Demographic and neuropathologic characteristics
From: [18F]-AV-1451 binding profile in chronic traumatic encephalopathy: a postmortem case series
Case N° | Pathological diagnosis | Age at death (years) | Gender | Braak & Braak (NFTs) | CERAD score (neuritic plaques) | NIA-Reagan Institute criteria |
|---|---|---|---|---|---|---|
1 | CTE (CTE stage III) | 46 | M | III | none | LP |
2 | CTE (CTE stage IV) | 65 | M | II | A | LP |
3 | CTE (CTE stage III) | 56 | M | II | none | LP |
4 | CTE (CTE stage II-III) | 25 | M | 0 | none | LP |
5 | CTE (CTE stage III) | 58 | M | III | none | LP |
6 | AD | 87 | F | V | Frequent | IP |
7 | AD | 71 | M | V | Moderate | IP |
8 | AD | 96 | F | V | Frequent | HP |
9 | AD | 82 | F | V | Moderate | HP |
10 | AD | 79 | M | V | Frequent | HP |
11 | AD | 66 | M | V | Moderate | HP |
12 | AD | 69 | F | VI | Frequent | HP |
13 | AD | 66 | F | VI | Frequent | HP |
14 | AD | 66 | F | VI | Frequent | HP |
15 | CTL | 76 | F | I | Sparse | LP |
16 | CTL | 97 | F | I | Sparse | LP |
17 | CTL | 81 | M | I | none | LP |
18 | CTL | 59 | F | I-II | Moderate | LP |
19 | CTL | 91 | M | II | none | LP |
20 | CTL | 101 | F | II | Moderate | LP |